Inhibition of Anaphylaxis by Ibrutinib

NCT03149315 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Food Allergy
Anaphylaxis Food

Interventions

DRUG: Ibrutinib

Sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Collaborators

[object Object]